The overall objective of this program project is to better understand mechanisms involved in the pathogenesis of macrovascular disease in diabetes, which is the major cause of morbidity and mortality in both type 1, and especially type 2 diabetes. Its goal is to better understand the genetic, cellular, biochemical and molecular nature of the premature atherosclerosis that characterizes the diabetic state. The program project is comprised of 4 inter-related projects and 3 cores. Project 17 will study the interaction of atherogenic lipoproteins with extracellular matrix molecules that result in the retention of these lipoproteins in the vascular wall, thereby enhancing atherosclerosis. It will focus on the regulation of these matrix molecules by factors associated with the diabetic state that facilitate lipoprotein retention. Project 21 is aimed at understanding why a subgroup of intensively-treated patients with type 1 diabetes develop features of type 2 diabetes such as central obesity, insulin resistance, and the associated cardiovascular risk factors that put these individuals at increased risk of premature cardiovascular and renal disease. Project 18 will study the role of diabetes on the regulation of the newly described cellular transporter, ABCA1, which plays a critical role in reverse cholesterol transport. Defects in the ability to remove cholesterol from the artery wall can result in increased atherogenesis. Project 20 will study the biochemical pathways involved in glycation and glycoxidation reactions that play a role in damaging various vascular lipids and proteins, thereby accelerating atherosclerosis in diabetes. These projects will be supported by an administrative and 2 scientific cores: The Arterial Tissue and Applied Pathology Core will provide 3 of the projects with arterial tissue from human subjects with diabetes and from several animal models. The Protein Chemistry Core will provide sophisticated biochemical support for the in vitro and in vivo studies proposed in all the projects. The increased understanding of the pathogenesis of the premature vascular disease in diabetes that will be derived from each of the projects has important therapeutic implications for the prevention and treatment of macrovascular disease in diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK002456-46
Application #
6879936
Study Section
Special Emphasis Panel (ZDK1-GRB-B (J2))
Program Officer
Jones, Teresa L Z
Project Start
1976-09-01
Project End
2007-03-31
Budget Start
2005-05-10
Budget End
2006-03-31
Support Year
46
Fiscal Year
2005
Total Cost
$2,304,131
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Hutchins, Patrick M; Heinecke, Jay W (2015) Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL. Curr Opin Lipidol 26:388-93
Vaisar, Tomáš; Tang, Chongren; Babenko, Ilona et al. (2015) Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity. J Lipid Res 56:1519-30
Hutchins, Patrick M; Ronsein, Graziella E; Monette, Jeffrey S et al. (2014) Quantification of HDL particle concentration by calibrated ion mobility analysis. Clin Chem 60:1393-401
Purnell, Jonathan Q; Zinman, Bernard; Brunzell, John D et al. (2013) The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interven Circulation 127:180-7
Umemoto, Tomio; Han, Chang Yeop; Mitra, Poulami et al. (2013) Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1. Circ Res 112:1345-54
Liu, Yuhua; Tang, Chongren (2012) Regulation of ABCA1 functions by signaling pathways. Biochim Biophys Acta 1821:522-9
de Boer, Ian H; Sachs, Michael C; Cleary, Patricia A et al. (2012) Circulating vitamin D metabolites and kidney disease in type 1 diabetes. J Clin Endocrinol Metab 97:4780-8
Hoofnagle, Andrew N; Wu, Mingyuan; Gosmanova, Albina K et al. (2010) Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia. Arterioscler Thromb Vasc Biol 30:2528-34
Tang, Chongren; Kanter, Jenny E; Bornfeldt, Karin E et al. (2010) Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys. J Lipid Res 51:1719-28
Vaisar, Tomás; Kassim, Sean Y; Gomez, Ivan G et al. (2009) MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages. Mol Cell Proteomics 8:1044-60

Showing the most recent 10 out of 24 publications